Effect of Hepatic Impairment on the Pharmacokinetics of Miricorilant: Results from a Phase 1, Open-Label, Adaptive-Design Study
Custodio et al. • 2025 • EASL 2025 Congress
Custodio et al. • 2025 • EASL 2025 Congress
Alkhouri et al. • 2025 • MASH-TAG 2025 Congress
Kowdley et al. • 2024 • AASLD 2024 Congress
Custodio et al. • 2024 • EASL 2024 Congress
Alkhouri et al. • 2024 • NASH-TAG 2024 Congress
Alkhouri et al. • 2024 • NASH-TAG 2024 Congress
Alkhouri et al. • 2023 • AASLD 2023 Congress
Kowdley et al • 2021 • The Liver Meeting 2021 (American Association for the Study of Liver Diseases)
Hunt et al • 2021 • Journal of Clinical Psychopharmacology: August 6, 2021
Lee et al. • 2020 • 2020 Annual Meeting – American Psychiatric Association (APA)
© 2024 Corcept Therapeutics, Incorporated